Redhawk Wealth Advisors »

Neurocrine Biosciences shares owned by Redhawk Wealth Advisors

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Redhawk Wealth Advisors from 13F filings

Historical chart of Redhawk Wealth Advisors investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Redhawk Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Redhawk Wealth Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.1M 9.6k 115.22
2024-06-30 $1.2M 8.8k 137.67
2024-03-31 $1.4M 9.9k 137.92
2023-12-31 $1.2M 9.4k 131.76

More positions owned by Redhawk Wealth Advisors

Vaneck Etf Trust Clo Etf (CLOI)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
Spdr Gold Tr Gold Shs (GLD)
Invesco Exchange Traded Fd T S&p 500 Top 50 (XLG)
NVIDIA Corporation (NVDA)
First Tr Exchange-traded Rba Indl Etf (AIRR)
Capital Grp Fixed Incm Etf T Us Multi-sector (CGMS)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Apple (AAPL)
Victory Portfolios Ii Short Trm Bd Etf (USTB)
Fidelity Covington Trust Enhanced Mid (FMDE)
J P Morgan Exchange Traded F Hedged Equity La (HELO)
J P Morgan Exchange Traded F Small & Mid Cap (JMEE)

View all positions for Redhawk Wealth Advisors

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
State Street Corporation
Dodge & Cox
Citadel Advisors
Renaissance Technologies
AQR Capital Management
Geode Capital Management
Bellevue Group
Morgan Stanley
T. Rowe Price Associates
Wellington Management Company
Jpmorgan Chase & Co
Ubs Global Asset Management Americas
Goldman Sachs Group

View all funds holding Neurocrine Biosciences